Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device.

BACKGROUND Axial-flow left ventricular assist devices (LVADs), when inactivated, may result in regurgitant blood flow. We assessed the effects of regurgitant pump flow with the intraventricular Jarvik 2000 Heart LVAD (Jarvik Heart, Inc., New York, NY) on hemodynamics and patient safety under pump-off conditions. METHODS Thirty patients being supported by a Jarvik 2000 as a bridge to heart transplantation underwent pump-off studies. Hemodynamics, vital signs and cognitive function were monitored; Doppler echocardiographic studies were done with the pump turned off for 5 minutes if tolerated. Regurgitant flow was assessed in terms of the difference between left ventricular and right ventricular outflow tract cardiac output (LVOT CO - RVOT CO). RESULTS During pump-off periods, the mean regurgitant flow was 0.42 +/- 0.41 liter/min, and the mean arterial blood pressure was 63.1 +/- 11.6 mm Hg. There was no regurgitant flow when the pump was on. Three patients did not tolerate the pump being off for periods of 5 minutes; in these tests, the mean regurgitant flow rate was 0.54 +/- 0.50 liter/min, the mean arterial blood pressure was 52.8 +/- 9.8 mm Hg, and the mean pump-off time was 3.1 +/- 1.1 minutes. All patients remained conscious during the pump-off period, and none showed lasting adverse effects. CONCLUSIONS Our findings suggest that patients being supported with the axial-flow Jarvik 2000 Heart LVAD can generally tolerate pump-off times of 5 minutes.

[1]  T. Myers,et al.  Assessment of myocardial recovery using dobutamine stress echocardiography in LVAD patients. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  A. Weyman.  Principles and Practice of Echocardiography , 1994 .

[3]  M. Loebe,et al.  Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. , 2005, Journal of the American College of Cardiology.

[4]  R K Jarvik,et al.  Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart. , 2001, The Annals of thoracic surgery.

[5]  Biswajit Kar,et al.  First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. , 2004, Texas Heart Institute journal.

[6]  J. Long,et al.  Simplified right-left balance for the implanted artificial heart , 1991 .

[7]  T. Myers,et al.  Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. , 2004, The Annals of thoracic surgery.

[8]  O. Frazier,et al.  Implantation of the permanent Jarvik-2000 left-ventricular-assist-device: surgical technique. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  T. Myers,et al.  Reverse Remodeling of the Failing Human Heart with Mechanical Unloading , 2003, Cardiology.

[10]  Friedhelm Beyersdorf,et al.  Implantation of the permanent Jarvik-2000 left ventricular assist device: a single-center experience. , 2002, Journal of the American College of Cardiology.

[11]  Yasmin Wadia,et al.  Echocardiographic evaluation of the Jarvik 2000 axial-flow LVAD. , 2005, Texas Heart Institute journal.

[12]  M. Hori,et al.  Noninvasive evaluation of the ratio of pulmonary to systemic flow in atrial septal defect by duplex Doppler echocardiography. , 1984, Circulation.

[13]  O. Frazier,et al.  Implant technique for the Jarvik 2000 Heart. , 2002, The Annals of thoracic surgery.

[14]  Stephen Westaby,et al.  Initial Clinical Experience With the Jarvik 2000 Implantable Axial-Flow Left Ventricular Assist System , 2002, Circulation.